Patent Number: 6,251,874

Title: Method of inhibiting human immunodeficiency virus using hydroxurea and a reverse transcriptase inhibitor in vivo

Abstract: A method for treating HIV infection in human beings comprising the step of measuring viremia, and if viremia is less than 50,000-100,00 copies per milliliter, administering a combination of compounds selected from the group consisting of hydroxyurea, and one or more reverse transcriptase inhibitors.

Inventors: Lisziewicz; Julianna (Bethesda, MD), Lori; Franco (Bethesda, MD)

Assignee: Research Institute for Genetic and Human Therapy (R.I.G.H.T.)

International Classification: A61K 45/06 (20060101); A61K 45/00 (20060101); A61K 031/07 (); A61K 031/17 ()

Expiration Date: 06/26/2018